I. Nikolaidis

发表

Reduced expression of L-selectin in T-cells correlates with relative lymphocyte increase in patients with RRMS treated with natalizumab - functional implication towards PML risk

P. Ioannidis, R. Lagoudaki, N. Grigoriadis, 2020, Neurological research.

Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response

N. Grigoriadis, E. Kesidou, M. Boziki, 2022, Cells.

Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece

P. Mitsias, G. Hadjigeorgiou, N. Grigoriadis, 2022, Neurology and Therapy.

Quality of life in people with multiple sclerosis receiving glatiramer acetate or interferon in Greek clinical practice.

D. Mitsikostas, A. Papadimitriou, C. Bakirtzis, 2022, Neurodegenerative disease management.

Shrimp sign in a case of progressive multifocal leukoencephalopathy under fingolimod treatment

N. Grigoriadis, S. Gerou, C. Bakirtzis, 2022, Neuroimmunology Reports.

Translation, cross-cultural adaptation, and validation of the Greek version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19.

F. Foley, A. Artemiadis, N. Grigoriadis, 2022, Somatosensory & motor research.

Induction of apoptosis in CD4(+) T-cells is linked with optimal treatment response in patients with relapsing-remitting multiple sclerosis treated with Glatiramer acetate

R. Lagoudaki, N. Grigoriadis, M. Boziki, 2019, Journal of the Neurological Sciences.

Cognitive Fatigability is Independent of Subjective Cognitive Fatigue and Mood in Multiple Sclerosis

A. Artemiadis, P. Ioannidis, N. Grigoriadis, 2020, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options

A. Artemiadis, G. Tsivgoulis, E. Dardiotis, 2019, Autoimmunity Highlights.

Congenital embryonal tumor of the central nervous system with a rapidly fatal outcome in the neonatal intensive care unit

P. Pavlidis, N. Grigoriadis, M. Boziki, 2022, Pediatric blood & cancer.

Blood Metabolomics May Discriminate a Sub-Group of Patients with First Demyelinating Episode in the Context of RRMS with Increased Disability and MRI Characteristics Indicative of Poor Prognosis

G. Theodoridis, H. Gika, N. Grigoriadis, 2022, International journal of molecular sciences.

Dysphagia Prevalence, Attitudes, and Related Quality of Life in Patients with Multiple Sclerosis

J. Constantinidis, N. Grigoriadis, S. Triaridis, 2019, Dysphagia.

Psychosis and conduct disorder in Greek forensic patients found not guilty by reason of insanity: Differences between patients with and those without a history of conduct disorder in childhood or adolescence.

Athanassios N. Avramidis, P. Pavlidis, M. Markopoulou, 2022, International journal of law and psychiatry.

Epidemiology of HIV-associated peripheral neuropathy in people living with human immunodeficiency virus infection in Greece

N. Grigoriadis, M. Boziki, L. Skoura, 2022, International journal of STD & AIDS.

Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options

A. Artemiadis, G. Tsivgoulis, E. Dardiotis, 2019, Autoimmunity Highlights.

Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: The IGNITE study

P. Ioannidis, G. Hadjigeorgiou, D. Langdon, 2018, Journal of the Neurological Sciences.

Death by compaction in a robotic dumpster

P. Pavlidis, M. Karakasi, I. Nikolaidis, 2023, Journal of forensic sciences.

The Administrative Prevalence of Multiple Sclerosis in Greece on the Basis of a Nationwide Prescription Database

D. Tsalikakis, N. Grigoriadis, T. Moysiadis, 2020, Frontiers in Neurology.

Deciphering anti-MOG IgG antibodies: Clinical and radiological spectrum, and comparison of antibody detection assays

M. Anagnostouli, G. Koutsis, N. Grigoriadis, 2020, Journal of the Neurological Sciences.

The modified DYMUS questionnaire is a reliable, valid and easy‐to‐use tool in the assessment of dysphagia in multiple sclerosis

N. Grigoriadis, M. Boziki, S. Triaridis, 2020, European journal of neurology.

Long-Term Efficacy Outcomes of Natalizumab vs. Fingolimod in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis: Real-World Data From a Multiple Sclerosis Reference Center

P. Ioannidis, N. Grigoriadis, M. Boziki, 2021, Frontiers in Neurology.

The Experience of a Tertiary Reference Hospital in the Study of Rare Neurological Diseases

P. Ioannidis, E. Dardiotis, G. Xiromerisiou, 2023, Medicina.

A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination

P. Bamidis, L. Probert, C. Styliadis, 2021, Frontiers in Neurology.

Reliability and validity of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis (Greek version) and proposed modification.

N. Grigoriadis, A. Printza, H. Proios, 2018, Multiple sclerosis and related disorders.

Churg-Strauss angiitis in a 64-years old woman with gait difficulty

P. Ioannidis, D. Karakostas, I. Nikolaidis, 2016 .

Epidemiological Insights on Medication Concurrency and Polypharmacy in People With Multiple Sclerosis in Greece.

N. Grigoriadis, T. Moysiadis, E. Kesidou, 2023, International journal of MS care.

Congenital Supratentorial Neuroectodermal Primary Tumor

P. Pavlidis, N. Grigoriadis, E. Giovannopoulou, 2022, The American journal of forensic medicine and pathology.

Association of cytokine gene polymorphisms with peripheral neuropathy susceptibility in people living with HIV in Greece

P. Pavlidis, M. Boziki, L. Skoura, 2023, Journal of NeuroVirology.

Emerging trends in domestic homicide/femicide in Greece over the period 2010–2021

P. Pavlidis, M. Markopoulou, A. Douzenis, 2022, Medicine, science, and the law.